TB Research

Acute Kidney Injury in Human Immunodeficiency Virus, Tuberculosis, and Human Immunodeficiency Virus/Tuberculosis Patients on Treatment and its Association with Host Predicting Factors, in South-West Region of Cameroon

Jude Eteneneng Enoh, Frederick Nchang Cho, Ngyah Ambo Agwa, Simon Eyongabane Ako, Faustin Pascal Tsagué Manfo, Anna Njunda Longdoh, Eric Achidi Akum

Journal of Preventive Diagnostic and Treatment Strategies in Medicine · 2023-04

Abstract

OBJECTIVES: To evaluate the incidence and severity of kidney injury and explore the host factors to predict acute kidney injury (AKI) among tuberculosis (TB), human immunodeficiency virus (HIV), and TB/HIV patients on the treatment in Fako Division of Cameroon. METHODS: A prospective study was carried out from September 2018 to November 2019. Serum creatinine and urea were measured spectrophotometrically. The Chi-square test with cox regression was used to assess the association between the risk factors and AKI. RESULTS: The overall incidence of AKI and renal injury was 21.4%–41.4%, respectively. Stage 1 AKI as well as mild renal injury was more prevailing among the HIV-infected patients; 10.5% versus 31.4%. The highest incidences; 30.0% AKI, and 53.0% renal injury were recorded amongst those with TB/HIV coinfections and HIV mono-infections, respectively. Persons who were ≥40 years and those with low baseline hemoglobin levels were two times and two and half times more likely to develop AKI compared to their counterparts. CONCLUSIONS: The cumulative incidence of AKI in patients on treatment was high. Thus, it is important to evaluate the renal function of patients before treatment within the first 2 weeks of treatment.

MeSH terms

  • Tuberculosis
  • Human immunodeficiency virus (HIV)
  • Virology
  • Host (biology)
  • Medicine
  • Virus
  • Immunology